LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | 959.0 | 189.0 | 9.0 | - | - | 1157 |
1 | - | - | - | - | - | 33.0 | 20.0 | - | - | - | 53 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | - |
1 | - |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 193 |
1 | 560 |
Number of post synapses: 1157
Number of pre synapses: 53
Number of output connections: 123
Coverage factor: 1.0
Columnar completeness: 0.20
Area completeness: 0.23
Cell size (columns): 174
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#MeVP27 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Cm1 (R) | ACh | 344 | 344.0 | 30.3% | 30.3% |
1 | MeVP2 (R) | ACh | 141 | 141.0 | 12.4% | 42.7% |
2 | MeVPMe7 (L) | Glu | 135 | 135.0 | 11.9% | 54.5% |
3 | Dm8a (R) | Glu | 80 | 80.0 | 7.0% | 61.6% |
4 | Cm19 (R) | GABA | 45 | 45.0 | 4.0% | 65.5% |
5 | TmY5a (R) | Glu | 44 | 44.0 | 3.9% | 69.4% |
6 | Cm7 (R) | Glu | 35 | 35.0 | 3.1% | 72.5% |
7 | Cm32 (R) | GABA | 32 | 32.0 | 2.8% | 75.3% |
8 | Cm3 (R) | GABA | 29 | 29.0 | 2.6% | 77.8% |
9 | Cm29 (R) | GABA | 28 | 28.0 | 2.5% | 80.3% |
10 | Cm26 (R) | Glu | 27 | 27.0 | 2.4% | 82.7% |
11 | TmY10 (R) | ACh | 21 | 21.0 | 1.8% | 84.5% |
12 | Cm2 (R) | ACh | 20 | 20.0 | 1.8% | 86.3% |
13 | Dm2 (R) | ACh | 20 | 20.0 | 1.8% | 88.0% |
14 | Cm31a (R) | GABA | 19 | 19.0 | 1.7% | 89.7% |
15 | Tm29 (R) | Glu | 13 | 13.0 | 1.1% | 90.9% |
16 | Cm21 (R) | GABA | 11 | 11.0 | 1.0% | 91.8% |
17 | Dm8b (R) | Glu | 8 | 8.0 | 0.7% | 92.5% |
18 | Cm17 (R) | GABA | 6 | 6.0 | 0.5% | 93.1% |
19 | MeLo3a (R) | ACh | 6 | 6.0 | 0.5% | 93.6% |
20 | MeVP41 (R) | ACh | 5 | 5.0 | 0.4% | 94.0% |
21 | Cm5 (R) | GABA | 4 | 4.0 | 0.4% | 94.4% |
22 | Cm8 (R) | GABA | 4 | 4.0 | 0.4% | 94.7% |
23 | Cm9 (R) | Glu | 4 | 4.0 | 0.4% | 95.1% |
24 | MeVP10 (R) | ACh | 4 | 4.0 | 0.4% | 95.4% |
25 | Dm9 (R) | Glu | 3 | 3.0 | 0.3% | 95.7% |
26 | MeTu4f (R) | ACh | 3 | 3.0 | 0.3% | 96.0% |
27 | MeVPMe7 (R) | Glu | 3 | 3.0 | 0.3% | 96.2% |
28 | Pm4 (R) | GABA | 3 | 3.0 | 0.3% | 96.5% |
29 | Tm37 (R) | Glu | 3 | 3.0 | 0.3% | 96.7% |
30 | Tm5a (R) | ACh | 3 | 3.0 | 0.3% | 97.0% |
31 | TmY17 (R) | ACh | 3 | 3.0 | 0.3% | 97.3% |
32 | Cm14 (R) | GABA | 2 | 2.0 | 0.2% | 97.4% |
33 | Cm15 (R) | GABA | 2 | 2.0 | 0.2% | 97.6% |
34 | Cm28 (R) | unclear | 2 | 2.0 | 0.2% | 97.8% |
35 | MeVC22 (R) | Glu | 2 | 2.0 | 0.2% | 98.0% |
36 | OA-ASM1 (L) | OA | 2 | 2.0 | 0.2% | 98.2% |
37 | OLVC2 (L) | GABA | 2 | 2.0 | 0.2% | 98.3% |
38 | Tm20 (R) | ACh | 2 | 2.0 | 0.2% | 98.5% |
39 | Cm10 (R) | GABA | 1 | 1.0 | 0.1% | 98.6% |
40 | Cm25 (R) | Glu | 1 | 1.0 | 0.1% | 98.7% |
41 | Cm31b (R) | GABA | 1 | 1.0 | 0.1% | 98.8% |
42 | Cm6 (R) | GABA | 1 | 1.0 | 0.1% | 98.9% |
43 | Li34b (R) | GABA | 1 | 1.0 | 0.1% | 98.9% |
44 | LT58 (R) | Glu | 1 | 1.0 | 0.1% | 99.0% |
45 | MeLo1 (R) | ACh | 1 | 1.0 | 0.1% | 99.1% |
46 | MeTu1 (R) | ACh | 1 | 1.0 | 0.1% | 99.2% |
47 | MeVP1 (R) | ACh | 1 | 1.0 | 0.1% | 99.3% |
48 | MeVP11 (R) | ACh | 1 | 1.0 | 0.1% | 99.4% |
49 | MeVP40 (R) | unclear | 1 | 1.0 | 0.1% | 99.5% |
50 | OA-ASM1 (R) | OA | 1 | 1.0 | 0.1% | 99.6% |
51 | OLVC4 (L) | unclear | 1 | 1.0 | 0.1% | 99.6% |
52 | Tm2 (R) | ACh | 1 | 1.0 | 0.1% | 99.7% |
53 | Tm26 (R) | ACh | 1 | 1.0 | 0.1% | 99.8% |
54 | Tm3 (R) | ACh | 1 | 1.0 | 0.1% | 99.9% |
55 | TmY20 (R) | ACh | 1 | 1.0 | 0.1% | 100.0% |
instance | NT | total connections | connections /#MeVP27 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | TmY10 (R) | ACh | 39 | 39.0 | 28.9% | 28.9% |
1 | MeVP2 (R) | ACh | 26 | 26.0 | 19.3% | 48.1% |
2 | MeVPMe7 (L) | Glu | 10 | 10.0 | 7.4% | 55.6% |
3 | Cm7 (R) | Glu | 5 | 5.0 | 3.7% | 59.3% |
4 | MeVP1 (R) | ACh | 5 | 5.0 | 3.7% | 63.0% |
5 | Cm29 (R) | GABA | 3 | 3.0 | 2.2% | 65.2% |
6 | MeLo4 (R) | ACh | 3 | 3.0 | 2.2% | 67.4% |
7 | MeVP52 (R) | ACh | 3 | 3.0 | 2.2% | 69.6% |
8 | TmY5a (R) | Glu | 3 | 3.0 | 2.2% | 71.9% |
9 | MeLo3a (R) | ACh | 2 | 2.0 | 1.5% | 73.3% |
10 | MeVP11 (R) | ACh | 2 | 2.0 | 1.5% | 74.8% |
11 | Tm29 (R) | Glu | 2 | 2.0 | 1.5% | 76.3% |
12 | TmY17 (R) | ACh | 2 | 2.0 | 1.5% | 77.8% |
13 | TmY18 (R) | ACh | 2 | 2.0 | 1.5% | 79.3% |
14 | TmY21 (R) | ACh | 2 | 2.0 | 1.5% | 80.7% |
15 | aMe4 (R) | ACh | 1 | 1.0 | 0.7% | 81.5% |
16 | aMe9 (R) | ACh | 1 | 1.0 | 0.7% | 82.2% |
17 | Cm1 (R) | ACh | 1 | 1.0 | 0.7% | 83.0% |
18 | Cm3 (R) | GABA | 1 | 1.0 | 0.7% | 83.7% |
19 | Cm31a (R) | GABA | 1 | 1.0 | 0.7% | 84.4% |
20 | Cm6 (R) | GABA | 1 | 1.0 | 0.7% | 85.2% |
21 | Cm8 (R) | GABA | 1 | 1.0 | 0.7% | 85.9% |
22 | Cm9 (R) | Glu | 1 | 1.0 | 0.7% | 86.7% |
23 | Dm8a (R) | Glu | 1 | 1.0 | 0.7% | 87.4% |
24 | LoVP96 (R) | Glu | 1 | 1.0 | 0.7% | 88.1% |
25 | MeLo7 (R) | ACh | 1 | 1.0 | 0.7% | 88.9% |
26 | MeTu3c (R) | ACh | 1 | 1.0 | 0.7% | 89.6% |
27 | MeVP10 (R) | ACh | 1 | 1.0 | 0.7% | 90.4% |
28 | MeVP3 (R) | ACh | 1 | 1.0 | 0.7% | 91.1% |
29 | MeVP42 (R) | ACh | 1 | 1.0 | 0.7% | 91.9% |
30 | MeVP47 (R) | unclear | 1 | 1.0 | 0.7% | 92.6% |
31 | MeVP7 (R) | ACh | 1 | 1.0 | 0.7% | 93.3% |
32 | MeVPMe12 (R) | ACh | 1 | 1.0 | 0.7% | 94.1% |
33 | OLVC2 (L) | GABA | 1 | 1.0 | 0.7% | 94.8% |
34 | Pm12 (R) | Glu | 1 | 1.0 | 0.7% | 95.6% |
35 | Pm8 (R) | GABA | 1 | 1.0 | 0.7% | 96.3% |
36 | T2a (R) | ACh | 1 | 1.0 | 0.7% | 97.0% |
37 | Tm30 (R) | GABA | 1 | 1.0 | 0.7% | 97.8% |
38 | Tm38 (R) | ACh | 1 | 1.0 | 0.7% | 98.5% |
39 | Tm5c (R) | Glu | 1 | 1.0 | 0.7% | 99.3% |
40 | Y13 (R) | Glu | 1 | 1.0 | 0.7% | 100.0% |